US EditionSartorius Stedim Biotech Signs Agreement with Nanotein
Summary by Gomet
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Sartorius Stedim Biotech, based in Aubagne and Nanotein Technologies (Berkeley, California), a new generation reagent developer for immune cell activation announced a partnership on August 11th. In this context, Sartorius Stedim Biotech will invest up to US$3 million in a minority stake in Nanotein Technologies to support the...This content is restricted for our subscribers!Subscribe from 24.99€ by monthUnlimited access to Gomet' contentParticip…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
